Online Safety Community

Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects

Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects for a number of valid reasons. One of the main reasons is that medical device regulatory and quality professionals are often responsible for overseeing the development of combination products that include small or large drug “active pharmaceutical ingredients” to achieve the clinical therapeutic effect.

In many pharmaceutical organizations, the medical device professional is often expected to take the lead role in overseeing all aspects of regulatory and quality compliance, including Chemistry, Manufacturing and Controls (CMC) aspects, particularly when the “primary mode of action” (PMOA) relates to the device component. It is here that Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects, because Regulatory and Quality engineers are often ill-equipped to manage the CMC aspects of projects.

This is because being technically trained personnel; they have scant knowledge of even the basic functions of the chemical, molecular structural, drug manufacturing process and analytical methods associated with the "active pharmaceutical ingredient" component.

Need to be able to understand technical elements of medical devices and combination drugs

Yet, that medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects cannot be ruled out, because since subtle chemical issues are integrally related to product performance, they need to be able to understand technical elements of medical devices and combination drugs.

The professional in charge of Regulatory Affairs (RA) needs to have a clear understanding of how drug chemistry impacts drug/device performance. The RA Lead needs to have answers to questions relating to:

o  The proper storage and environmental condition for simple molecules, peptides, polypeptides and proteins

o  The ways in which the drug impurity levels change as the product is combined with the device components

o  The way “Quality by Design” (QbD) ensures drug performance

o  The methods by which an analytical method should be validated to meet FDA CDER requirements

o  The indicia of drug stability

Since it is questions such as these that frequently arise during FDA product evaluation, Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects.

A major learning session to help understand these aspects

Compliance4All, a leading provider of professional trainings for all the areas of regulatory compliance, will organize a learning session to help understand these aspects, at which these and related aspects of managing drug and device combination product project will be imparted.

The speaker at this webinar is Robert Michalik J.D, RAC, a Massachusetts regulatory attorney and founder of RegulatoryPro.com, a consulting firm providing general and specialized services to the biopharmaceutical and medical device industries. To enrol for this webinar, please visit

http://www.compliance4all.com/control/w_product/~product_id=501077L...

Robert will familiarize participants with the basics of small molecule and larger molecule (protein chemistry) development and testing. Using this as the basis, he will offer real world practical situations that arise in this field, which will help participants to become aware of how to spot problems that are a routine occurrence in every product development program. Being able to spot a CMC problem is more important than having the knowledge to fix it, because the FDA does not expect a company to solve it, but rather that it understands how the agency locates the problem.

Robert will cover the following areas at this session:

Chemistry 101: A review of the basics

  • Molecular structure and its impact on drug activity (smaller molecules behave differently from larger molecules)
  • Techniques commonly used in drug synthesis, manufacturing and quality control testing.
  • CMC Regulatory Compliance: Brief but comprehensive review of the essentials
  • How to spot a CMC-related problem and what to do when you suspect one.
  • Case studies that illustrate common issues that arise relating to drug components in combination device products
  • FAQs and Essential follow-up reading for those who want more resources

Views: 8

Comment

You need to be a member of Online Safety Community to add comments!

Join Online Safety Community

Take our poll!

Take our poll!

Latest Activity

Adam Fleaming posted a blog post

Effective cleaning validation procedures for analytical equipment

Regulatory agencies the world over have put in place stringent requirements for ensuring that cleaning validation procedures for analytical equipment are effective. Even if putting these practices in place involves expense and effort, it is worth the trouble, because the cost of noncompliance is much, much higher than that of compliance.Noncompliance with regulations for cleaning validation procedures for analytical equipment has a serious consequence: Regulatory bodies such as the FDA could…See More
4 minutes ago
David Collins posted a blog post

What is the real role of a safety advisor?

The Role of Safety Advisor in Organisations – Essential ReadingWhilst everyone wants to do ‘safety differently’, it is not likely that reform will come within. The paradigm of safety with its primary focus on measurement actually mitigates any hope of innovation, creativity or critical thinking. If safety is now the…See More
7 hours ago
Prawit is now a member of Online Safety Community
22 hours ago
Adam Fleaming posted a blog post

Establishing Latest Quality Systems in medical device and pharmaceutical industries

Establishing Quality Systems is one of the central aspects of a medical device and/or pharmaceutical organization. Establishment of Quality Systems is also a regulatory requirement, as set out by the FDA and the ISO.The process of establishment of Quality Systems for FDA-regulated medical devices industries is set out in 21 CFR Part 820. Further, the ISO has its standard for how to establish Quality Systems in medical devices industries –the ISO 13485 standard –which has to be implemented as…See More
yesterday

Forum

What's your favorite motivational/safety quote? 97 Replies

Favorite Motivational Quote: If you want something, you'll find a way - If not, you'll find an excuse.Favorite Safety Quote: Don't learn safety by accident!Continue

Started by Michelle Sears. Last reply by David Collins 6 hours ago.

OSHA and Machine Guard Door Safety???

We have what we feel is not a unique situation and were wondering if anyone might of run across this challenge and know more about the requirements.  We are building a small machine system that…Continue

Tags: electric, osha, air, door, interlocked

Started by Scott V on Friday.

OSHA 500 and 510 9 Replies

Hey Guys,How many of you have taken the 510 and 500 OSHA Trainer course? I am thinking about taking these 2 classes and become an OSHA trainer for my company. What are your guys thoughts on the…Continue

Started by Alfred Good. Last reply by Mymic Mar 15.

OSHA Training, Standards & Best Practices 3 Replies

Get trained on OSHA regulations affecting your industry through online webinars, learn the best practices, and download quality standards, checklists and news articles. Listen to experts on best…Continue

Tags: Webinar, Training, 2011, OSHA, compliance

Started by admin. Last reply by Mymic Mar 15.

FORKLIFT TRAINING CLASSES 21 Replies

Any ideas on how to make Forklift Training Classes more interesting and fun?

Started by Marcia Whatley. Last reply by Mymic Mar 15.

Badge

Loading…

© 2017   Created by Safety Community.   Powered by

Badges  |  Report an Issue  |  Terms of Service